title: A case report of putative autoimmunity to prostate cancer after immune-mediated rejection of melanoma through a shared tumor antigen.
authors.affiliation: Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
authors.forename: Polly
authors.initials: P
authors.lastname: Gregor
authors.forename: Q Daisy
authors.initials: QD
authors.lastname: Huang
authors.forename: Humilidad F
authors.initials: HF
authors.lastname: Gallardo
authors.forename: Teresa S
authors.initials: TS
authors.lastname: Rasalan
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Morris
mesh_terms: D000230:Adenocarcinoma / Q000097:blood / Q000188:drug therapy / Q000276:immunology*; D000369:Aged, 80 and over; D000912:Antibodies, Neoplasm / Q000097:blood; D000951:Antigens, Neoplasm / Q000276:immunology / Q000378:metabolism*; D000970:Antineoplastic Agents / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000097:blood; D003131:Combined Modality Therapy; D000077143:Docetaxel; D017809:Fatal Outcome; D043425:Glutamate Carboxypeptidase II / Q000276:immunology / Q000378:metabolism*; D006801:Humans; D007167:Immunotherapy; D008297:Male; D008545:Melanoma / Q000097:blood / Q000276:immunology* / Q000628:therapy; D009362:Neoplasm Metastasis; D016609:Neoplasms, Second Primary / Q000097:blood / Q000188:drug therapy / Q000276:immunology*; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000097:blood / Q000188:drug therapy / Q000276:immunology*; D012878:Skin Neoplasms / Q000097:blood / Q000276:immunology* / Q000628:therapy; D043823:Taxoids / Q000627:therapeutic use
chemical_list: D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D043823:Taxoids; D000077143:Docetaxel; D043425:Glutamate Carboxypeptidase II; D017430:Prostate-Specific Antigen